Related Experiment Video
Updated: Nov 29, 2025

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
Published on: September 26, 2025
A Novel Eutectic-Based Transdermal Delivery System for Risperidone
Faisal Al-Akayleh1, Samer Adwan2, Mai Khanfar3
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy and Medical Sciences, Petra University, Amman, Jordan.
Researchers developed novel therapeutic deep eutectic solvents (THEDES) using risperidone and fatty acids. These formulations significantly enhanced drug solubility and skin permeation, showing potential for improved drug delivery with no irritation.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Drug Delivery Systems
Background:
- Risperidone (RIS) is an antipsychotic medication with limited aqueous solubility.
- Traditional formulations may not optimize RIS delivery and efficacy.
- Deep Eutectic Solvents (DES) offer potential for enhancing drug solubility and permeation.
Purpose of the Study:
- To investigate the formation of novel room temperature therapeutic deep eutectic solvents (THEDES) of risperidone with capric acid (CA) and lauric acid (LA).
- To characterize the physicochemical properties of these THEDES.
- To evaluate the potential of THEDES for enhancing RIS skin permeation.
Main Methods:
- Preparation and characterization of RIS-fatty acid mixtures.
- Differential Scanning Calorimetry (DSC) for phase diagram construction and melting point determination.
- Freeze-drying microscopy for phase transition analysis.
- Solubility studies, skin permeation assays, rheological measurements, and in vivo skin irritation tests.
Main Results:
- Novel liquid THEDES of RIS with CA and LA were successfully formed at room temperature.
- Lowest melting points achieved were 17°C (RIS:CA, 40:60% w/w) and 22°C (RIS:LA, 30:70% w/w).
- RIS solubility increased up to 70,000-fold compared to water.
- Significant enhancement (P < 0.05) in RIS skin permeation was observed.
- THEDES formulations exhibited temperature-dependent viscosity, fitting the Arrhenius equation.
- No skin irritation or edema was observed in rat models.
Conclusions:
- Novel RIS-based THEDES with capric acid and lauric acid offer a promising platform for enhanced drug delivery.
- These formulations significantly improve RIS solubility and skin permeation.
- The developed THEDES are safe for topical application, demonstrating potential for improved risperidone therapy.
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...

